West Pharmaceutical Services Inc (WST)

Currency in USD
252.94
-4.82(-1.87%)
Closed·
After Hours
251.72-1.22(-0.48%)
·
WST Scorecard
Full Analysis
Management has been aggressively buying back shares
WST is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
251.47258.15
52 wk Range
187.43352.33
Key Statistics
Prev. Close
257.76
Open
256.23
Day's Range
251.47-258.15
52 wk Range
187.43-352.33
Volume
953.32K
Average Volume (3m)
720.51K
1-Year Change
-12.21%
Book Value / Share
40.77
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WST Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
316.36
Upside
+25.07%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 33 consecutive years
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

West Pharmaceutical Services Inc Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $1.84 and revenue of $766.5M beat estimates; stock surged 22.74% in premarket trading
  • Organic sales grew 6.8%; full-year 2025 sales guidance raised to $3.040-$3.060B with 3-3.75% organic growth expected
  • Gross profit up 19.1% YoY to $273.9M; gross margin improved 290 bps to 35.7%; adjusted operating profit margin up 230 bps to 20.3%
  • Strong demand for HVP components and biologics market solutions driving growth; company expanding manufacturing capacity
  • Management anticipates stronger H2 2025 performance, driven by biologics and diabetes markets; adjusted EPS guidance at $6.65-$6.85
Last Updated: 24/07/2025, 14:30
Read Full Transcript

Compare WST to Peers and Sector

Metrics to compare
WST
Peers
Sector
Relationship
P/E Ratio
37.3x12.4x−0.5x
PEG Ratio
−7.42−0.290.00
Price/Book
6.2x1.1x2.6x
Price / LTM Sales
6.1x1.3x3.2x
Upside (Analyst Target)
27.0%34.7%42.0%
Fair Value Upside
Unlock24.6%6.6%Unlock

Analyst Ratings

11 Buy
2 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 316.36
(+25.07% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.73%
Dividend Yield
0.35%
Industry Median 1.34%
Annualised payout
0.88
Paid quarterly
5-Years Growth
+5.67%
Growth Streak

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
1.84 / 1.51
Revenue / Forecast
766.50M / 725.26M
EPS Revisions
Last 90 days

WST Income Statement

People Also Watch

99.48
PCAR
-1.15%
25.53
CNC
-4.95%
476.56
BRKb
-1.07%
105.03
VLTO
+1.87%
206.85
DHR
+1.93%

FAQ

What Stock Exchange Does West Pharmaceutical Services Trade On?

West Pharmaceutical Services is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for West Pharmaceutical Services?

The stock symbol for West Pharmaceutical Services is "WST."

What Is the West Pharmaceutical Services Market Cap?

As of today, West Pharmaceutical Services market cap is 18.16B.

What Is West Pharmaceutical Services's Earnings Per Share (TTM)?

The West Pharmaceutical Services EPS (TTM) is 6.73.

When Is the Next West Pharmaceutical Services Earnings Date?

West Pharmaceutical Services will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is WST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has West Pharmaceutical Services Stock Split?

West Pharmaceutical Services has split 4 times.

How Many Employees Does West Pharmaceutical Services Have?

West Pharmaceutical Services has 10600 employees.

What is the current trading status of West Pharmaceutical Services (WST)?

As of 30 Jul 2025, West Pharmaceutical Services (WST) is trading at a price of 252.94, with a previous close of 257.76. The stock has fluctuated within a day range of 251.47 to 258.15, while its 52-week range spans from 187.43 to 352.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.